Other OTC - Delayed Quote USD

Vaso Corporation (VASO)

0.2948 -0.0048 (-1.60%)
As of 3:08 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Jun Ma Ph.D. President, CEO & Director 921.61k -- 1963
Mr. Jonathan P. Newton Co-CFO & Treasurer 368.78k -- 1961
Mr. Michael J. Beecher CPA, CPA Co-CFO & Secretary 149.57k -- 1945
Mr. Peter C. Castle Chief Operating Officer 442k -- 1968
Ms. Jane Moen President of VasoHealthcare & Director 729.44k -- 1980
Mr. Shen Qiuming President of Biox Instruments Co Ltd -- -- --
Mr. Randy Hill Consultant 105k -- 1947
Dr. Derek Enlander M.D. Advisor 12k -- 1946

Vaso Corporation

137 Commercial Street
Unit 200
Plainview, NY 11803
United States
516 997 4600 https://vasocorporation.com
Full Time Employees: 
300

Description

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Corporate Governance

Vaso Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 13, 2024 - May 17, 2024
Vaso Corporation Earnings Call

Related Tickers

KSIOF kneat.com, inc.
2.7273
-0.46%
 
EQS.PA Equasens Société anonyme
58.10
-1.36%
 
TALK Talkspace, Inc.
3.1200
+5.05%
 
AUGX Augmedix, Inc.
2.9150
-3.16%
 
OPRX OptimizeRx Corporation
9.19
-1.77%
 
RCM R1 RCM Inc.
11.94
-0.71%
 
FOXO FOXO Technologies Inc.
0.2670
-3.68%
 
SHCR Sharecare, Inc.
0.6378
+0.62%
 
PGNY Progyny, Inc.
32.51
+1.98%
 
GDRX GoodRx Holdings, Inc.
6.70
-0.45%